Dementia

source

South Africa Seizes Illegal...

Illegal weight-loss medicines containing semaglutide and tirzepatide were seized in...

Alzheimer’s Disease: APP Processing...

In this video, we will cover the signaling events involved in the processing...

What Is Behind the...

India has intensified Ebola surveillance after suspected travel-linked cases were...
HomeMental healthMQ announces a...

MQ announces a new CEO


MQ Mental Health Research is delighted to announce that Chris Jarrett has been appointed as their new CEO. Chris joins MQ from Prostate Cancer UK where he was Director of Fundraising & Supporter Engagement.

Chris comes to MQ with a strong track record of fundraising and team leadership with 20 years of experience in the research and medical charity sector, including roles as Chief Income Officer at the RNIB, and at the British Heart Foundation, Asthma UK and the Samaritans.

I’m really excited to be joining MQ.” Says Chris.

“Mental Health is a cause that is very close to my heart. I have 3 children growing up in a world where more young people are struggling with their mental health. So, the opportunity to be a part of an organisation working to create a better understanding of the causes and the road to better support for mental health is really motivating to me.”

Chris will be taking up his position on the 2nd of March. He joins MQ at an exciting time as the charity is funding more research than ever before with 25 active grants across five continents, with more launching in 2026 and many live research partnerships in the USA and Europe.

Chris is taking over from Chris Martin who has been MQ’s Interim CEO since the summer of 2025.

“We are very pleased to be welcoming Chris to MQ. “ shared Dr Shahzad Malik, Chair of MQ .

“With his impressive fundraising experience, we are excited to see him lead the charity into our next phase of growth as we continue to champion the need for substantially more funding of research in mental health sciences.”

MQ Mental Health Research is committed to supporting high-quality scientific research into different mental health conditions all around the world so that we can better help the 1 in 4 people impacted by mental illness.

The post MQ announces a new CEO first appeared on MQ Mental Health Research.

Continue reading

South Africa Seizes Illegal Weight-Loss Medicines

Illegal weight-loss medicines containing semaglutide and tirzepatide were seized in South Africa after inspections uncovered serious safety, quality, and compliance issues.

Alzheimer’s Disease: APP Processing & Amyloid Plaque Formation

In this video, we will cover the signaling events involved in the processing of Amyloid Precursor Protein, commonly called APP, that leads to the formation of Amyloid Plaque. To Learn More About Alzheimer's Disease Signaling Visit Learn more about...